Clinical Trial Update: Intravitreal Bevacizumab Pretreatment for Reducing Preretinal Hemorrhage in Diabetic Vitrectomy

View source ↗

Summary

A completed clinical trial evaluating intravitreal bevacizumab pretreatment to reduce preretinal hemorrhage during diabetic vitrectomy in proliferative diabetic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Proliferative Diabetic Retinopathy | Status: COMPLETED